Evaxion Biotech
$7.079876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$7.07
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$0.56 (+8.60%) As of 7:32 PM UTC today
Why Robinhood?
You can buy or sell EVAX and other stocks, options, and ETFs commission-free!
About EVAX
Evaxion Biotech A/S discovers and develops novel immunotherapies for cancer and infectious diseases. The company was founded by Niels Iversen Møller and Andreas Holm Mattsson on 11 August, 2008 and is headquartered in Copenhagen, Denmark.
CEO
Lars Aage Staal Wegner
Employees
35
Headquarters
Copenhagen, North Denmark
Founded
2008
Market Cap
98.96M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
176.51K
High Today
$7.28
Low Today
$6.54
Open Price
$6.54
Volume
94.50K
52 Week High
$10.34
52 Week Low
$5.16
EVAX Earnings
-$0.25
-$0.17
-$0.08
$0.00
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Available May 13